New Delhi, April 14, 2026: The Prime Minister today shared an insightful article underscoring India’s growing prominence and strategic strength in the global pharmaceutical sector. The article highlights how India continues to emerge as a trusted hub for affordable, high-quality medicines, vaccines, and innovative healthcare solutions.
Emphasizing the nation’s expanding capabilities, the Prime Minister noted that India’s pharmaceutical industry has become a key pillar of global healthcare supply chains. From life-saving generic medicines to cutting-edge vaccine production, India is playing a crucial role in ensuring healthcare accessibility across continents.
The shared article outlines major advancements in research and development, robust manufacturing infrastructure, and policy-driven growth that have positioned India among the top pharmaceutical producers worldwide. It also highlights the sector’s contribution to economic growth, employment generation, and global health resilience.
The Prime Minister reaffirmed the government’s commitment to further strengthening the ecosystem through innovation, ease of doing business, and support for startups and MSMEs in the pharma space. He encouraged stakeholders to continue leveraging India’s scientific talent and technological capabilities to drive the next phase of growth.
India’s pharmaceutical sector, often referred to as the “Pharmacy of the World,” continues to set benchmarks in quality, affordability, and scale—reinforcing the country’s leadership in global healthcare.
